Sanofi to buy Bioverativ

Sanofi (NYSE: SNY) will pay a premium of approximately $11.6 billion in cash to acquire Bioverativ Inc. (Nasdaq: BIVV). Shares of Sanofi dropped $1.40 to close at $43.20 while Bioverativ stop leaped $39.68 to close at $103.79.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.